HIGHLIGHTS
- who: Katia Sayaf et al. from the Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy have published the paper: The Nuclear Receptor PXR in Chronic Liver Disease, in the Journal: Cells 2022, 61 of /2022/
- what: Many in_vitro and in_vivo studies demonstrated the involvement of PXR in chronic liver diseases of different etiologies, together with its known xenosensor function, operated by modulating the expression of drug metabolizing enzymes and drug transporters.
- future: More studies are needed to unravel whether PXR plays a role in the development and the progression of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.